Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location.

• Authors: Stefan Kasper, Caroline Foch, Regina Esser, Francois-Xavier Lamy, Aimar Zhang, Ann-Lii Cheng, Magali Rouyer, Thomas Brodowicz, Christoph Zielinski
• Journal: European journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 180 Pg. 85-88 (02 2023) ISSN: 1879-0852 [Electronic] England
• PMID: 36563490 (Publication Type: Letter, Research Support, Non-U.S. Gov't)

Chemical References

• Cetuximab
• Antineoplastic Agents, Immunological
• Proto-Oncogene Proteins p21(ras)

Topics

• Humans
• Cetuximab (therapeutic use)
• Colorectal Neoplasms (drug therapy, genetics)
• Antineoplastic Agents, Immunological (therapeutic use)
• Colonic Neoplasms (drug therapy)
• Rectal Neoplasms (drug therapy)
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Proto-Oncogene Proteins p21(ras)